Zer egin paziente baten behar klinikoak asetzeko sendagaiak osasun-sistema publikoko farmazia-prestazioaren barruan ez badaude?

  1. Garcia de Andoin Barandiaran, Josune 1
  2. Umerez Igartua, Maitane 2
  3. Ercilla Liceaga, Miren 1
  4. Landa Alberdi, June 1
  5. Leunda Eizmendi, Larraitz 1
  6. Urretavizcaya Anton, Mikel 3
  7. Lizardi Mutuberria, Aitziber 3
  1. 1 Hospital Universitario de Donostia
    info

    Hospital Universitario de Donostia

    San Sebastián, España

    ROR https://ror.org/04fkwzm96

  2. 2 Mendaro Ospitalea
  3. 3 Onkologikoa Fundazioa
Journal:
Osagaiz: osasun-zientzien aldizkaria

ISSN: 2530-9412

Year of publication: 2021

Volume: 5

Issue: 1

Pages: 137-140

Type: Article

DOI: 10.26876/OSAGAIZ.1.2021.366 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Osagaiz: osasun-zientzien aldizkaria

Abstract

There may be situations where the clinical needs of a patient can not be covered with a drug included in the pharmaceutical-provision of the public health system. There are different options for obtaining it: off-label use, acquisition of a foreign medicine, compassionate use of research drug or participation in a clinical trial. In these cases, a special request must be made to the Spanish Agency for Medicines and Health Products and/or to the hospital authorities. The reports to be submitted will clearly state the essential need for the drug and it is also mandatory to obtain informed consent from the patient.